Cancer Therapeutics and Supportive Care Drugs Market

The cancer supportive care product market consists of drugs intended to prevent or treat the symptoms of cancer, and reduce the side effects of cancer treatments. Instead of extending a patient?s life expectancy, the emphasis is on improving overall quality of life. The key indications covered in Cancer Therapeutics and Supportive Care Drugs Market are cancer pain, oral mucositis, chemotherapy-induced neutropenia (CIN), chemotherapy-induced anemia (CIA), chemotherapy-induced nausea and vomiting (CINV) and bone metastasis. These indications are not only distressing for patients, but can also lead to treatment cessation, which in turn increases patient mortality. As the number of people being diagnosed with cancer grows and access to effective treatment that allows patients to survive longer increases, demand for safe and effective cancer supportive care drugs will rise.

Cancer Therapeutics and Supportive Care Drugs Market contains market size and forecasts of Cancer Therapeutics and Supportive Care Drugs in Global, including the following market information:

• Global Cancer Therapeutics and Supportive Care Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global top five companies in 2021 (%)
• The global Cancer Therapeutics and Supportive Care Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
• The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
• Cancer Therapeutics Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Cancer Therapeutics and Supportive Care Drugs include Abbott Laboratories, AstraZeneca plc, Astellas Pharma, Bristol-Myers Squibb, Johnson & Johnson, Eli Lilly, Novartis, Pfizer and Sanofi, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Cancer Therapeutics and Supportive Care Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Cancer Therapeutics and Supportive Care Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Cancer Therapeutics and Supportive Care Drugs Market Segment Percentages, by Type, 2021 (%)

• Cancer Therapeutics
• Supportive Care Drugs

Global Cancer Therapeutics and Supportive Care Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Cancer Therapeutics and Supportive Care Drugs Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Retail Pharmacies

Global Cancer Therapeutics and Supportive Care Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Cancer Therapeutics and Supportive Care Drugs Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Cancer Therapeutics and Supportive Care Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
• Key companies Cancer Therapeutics and Supportive Care Drugs revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Abbott Laboratories
• AstraZeneca plc
• Astellas Pharma
• Bristol-Myers Squibb
• Johnson & Johnson
• Eli Lilly
• Novartis
• Pfizer
• Sanofi
• Teva Pharmaceuticals
• Takeda Pharmaceuticals
• AbbVie